ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.91
0.06%
US Tech 100
18,244.80
0.27%
S&P 500
5,321.41
0.25%
US Dollar vs CAD
1.36428
0.01%
Bitcoin
69,510.62
-0.88%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Kronos Bio Inc (KRON)

  7. Kronos Bio Inc (KRON) News

KRON

Kronos Bio (KRON)

Kronos Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KRON
DateTimeSourceHeadlineSymbolCompany
05/21/20243:15PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:KRONKronos Bio Inc
05/21/20247:20AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRONKronos Bio Inc
05/21/20247:15AMGlobeNewswire Inc.Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer NASDAQ:KRONKronos Bio Inc
05/09/20243:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRONKronos Bio Inc
05/09/20243:08PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KRONKronos Bio Inc
05/09/20243:05PMGlobeNewswire Inc.Kronos Bio Reports First-Quarter 2024 Financial ResultsNASDAQ:KRONKronos Bio Inc
04/24/20243:01PMGlobeNewswire Inc.Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:KRONKronos Bio Inc
03/21/20246:05AMGlobeNewswire Inc.Kronos Bio Reports Recent Business Progress and Fourth-Quarter and Full-Year 2023 Financial ResultsNASDAQ:KRONKronos Bio Inc
03/07/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRONKronos Bio Inc
03/07/20243:05PMGlobeNewswire Inc.Kronos Bio Announces Restructuring to Focus Resources on Clinical Development with Extended Cash RunwayNASDAQ:KRONKronos Bio Inc
03/05/20243:44PMGlobeNewswire Inc.Kronos Bio To Present Three Posters at AACR 2024 Annual MeetingNASDAQ:KRONKronos Bio Inc
03/05/20246:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRONKronos Bio Inc
02/27/20243:05PMGlobeNewswire Inc.Kronos Bio Announces Participation in 44th Annual Cowen Health Care ConferenceNASDAQ:KRONKronos Bio Inc
02/23/20247:07PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
02/23/20247:06PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
02/23/20247:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
02/23/20247:03PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
01/25/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRONKronos Bio Inc
01/05/20245:30PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
01/05/20245:27PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
01/05/20245:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
12/18/20233:06PMGlobeNewswire Inc.Kronos Bio Announces Pipeline Update and p300 KAT Inhibitor Development CandidateNASDAQ:KRONKronos Bio Inc
12/13/20233:10PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
12/13/20233:09PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:KRONKronos Bio Inc
12/04/20237:00AMGlobeNewswire Inc.Kronos Bio Announces Participation in H.C. Wainwright 4th Annual Precision Oncology Virtual ConferenceNASDAQ:KRONKronos Bio Inc
11/27/20233:05PMGlobeNewswire Inc.Kronos Bio Announces Participation in 35th Annual Piper Sandler Healthcare ConferenceNASDAQ:KRONKronos Bio Inc
11/13/20233:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRONKronos Bio Inc
11/13/20233:05PMGlobeNewswire Inc.Kronos Bio Reports Recent Business Progress and Third-Quarter 2023 Financial ResultsNASDAQ:KRONKronos Bio Inc
11/13/20233:04PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:KRONKronos Bio Inc
11/02/20233:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:KRONKronos Bio Inc
 Showing the most relevant articles for your search:NASDAQ:KRON

Your Recent History

DBI
2DWR
DAX Risk Control 10% RV ...
USOTC
LRLCY
Loreal (PK)
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved